Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Lymphoma (BASKET).php on line 2
Lymphoma (BASKET)
LE WE PMID CA
Lymphoma (BASKET)1670Lymphom (allg)

Antibodies (Immungenetics)

Arthritis (rheumatoid)

Bacillus calmette guerin

Bartonella henselae

Bone marrow (Imaging)

Bone marrow transplantation

Calcium (Hypercalciemia)

Candida (BASKET)

Coccidioidomycosis

Crohn s disease

Cryptococcosis

Enzastaurin

Everolimus

Fat necrosis subcutaneous of the newborn

Fostamatinib

Gastrointestinal stromal cell tumor GIST

Hepatitis G

Histoplasmosis

Ibritumomab tiuxentan yttrium ttCD20

Immunotherapy (Adoptive cell transfer)

Langerhans cell histiocytosis

Lepra

Leukemia (chronic lymphatic)

Liver (Diseases)

Lung (Lipoid pneumonia)

Lung (Toxicology)

Lung and bronchial system (Neoplasia)

Lymphoma (B cell diffuse large)

Lymphoma (BASKET)

Lymphoma (Hodgkin)

MTOR

Mycobacterium avium

Osteoarthritis

Ovary (Neoplasia)

Paracoccoidomycosis

Pneumocystis carinii Pneumocystis jirovicii

Polymyositis

Protein kinase C beta

Pseudolymphoma (Lymphomatoid granulomatosis)

Pseudolymphoma (Plasma cell granuloma)

Radiation therapy

Ridaforolimus ttMTOR

Sarcoidosis

Silicone

Slack skin disease

Syk

Temsirolimus

Testis (Neoplasia Seminoma)

Testis (Neoplasia)

Tuberculosis

Vaccine (Oncology)

Wegener s granulomatosis

1998  
1
Intravascular malignant lymphomatosis with neurologic presentation: factors facilitating antemortem diagnosis.
[9671843] South Med J 91(7): 672-6 (1998)
2005  
2
CD4+CD56+ lineage negative hematopoietic neoplasm: so called blastic NK cell lymphoma.
[15832009] J Korean Med Sci 20(2): 319-24 (2005)
2009  
3
Novel antibodies in the treatment of non-Hodgkin's lymphoma.
[19767657] Neth J Med 67(8): 311-21 (2009)
2009  
4
CD20-targeted therapy: a breakthrough in the treatment of non-Hodgkin's lymphoma.
[19687518] Neth J Med 67(7): 251-9 (2009)
2006  
5
Skin manifestation of mantle cell lymphoma.
[16935806] Eur J Dermatol 16(4): 435-8 (2006)
2009  
6
Angiogenesis and antiangiogenic therapy in non-Hodgkin's lymphoma.
[19088170] Ann Oncol 20(3): 413-24 (2009)
2008  
7
New response criteria for lymphomas in clinical trials.
[18519399] Ann Oncol 19 Suppl 4(-): iv35-8 (2008)
2008  
8
Autoimmune disorders and lymphoma.
[18519398] Ann Oncol 19 Suppl 4(-): iv31-4 (2008)
1997  
9
Non-Hodgkin's lymphomas: current classification and management.
[9371057] CA Cancer J Clin 47(6): 351-72 (1997)
1971  
10
2001  
11
2008  
12
Evidence mounts for the efficacy of radioimmunotherapy for B-cell lymphomas.
[18854559] J Clin Oncol 26(32): 5147-50 (2008)
1997  
13
2004  
14
Clinical mimics of lymphoma.
[15266094] Oncologist 9(4): 406-16 (2004)
2008  
15
Stroma-initiated hedgehog signaling takes center stage in B-cell lymphoma.
[18281468] Cancer Res 68(4): 961-4 (2008)
1997  
16
Disorders that resemble lymphomas.
[9298871] Am J Hematol 56(1): 63-8 (1997)
2008  
17
Classification of lymphoid neoplasms: the microscope as a tool for disease discovery.
[19029456] Blood 112(12): 4384-99 (2008)
2008  
18
Imaging in staging of malignant lymphoma: a systematic review.
[17916746] Blood 111(2): 504-16 (2008)
2007  
19
Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph).
[17389762] Blood 110(2): 695-708 (2007)
2009  
20
The incidence, natural history, biology, and treatment of transformed lymphomas.
[20008238] Hematology Am Soc Hematol Educ Program -(-): 532-41 (2009)
2007  
21
2004  
22
2001  
23
2005  
24
Best Practice No 185. Cytological and molecular diagnosis of lymphoma.
[15917402] J Clin Pathol 58(6): 561-7 (2005)
2007  
25
Anatomic and functional imaging in the management of lymphoma.
[17538524] Q J Nucl Med Mol Imaging 51(3): 251-9 (2007)
2003  
26
90Y-ibritumomab tiuxetan in the treatment of relapsed or refractory B-cell non-Hodgkin's lymphoma.
[12777454] J Nucl Med Technol 31(2): 61-8; quiz 69-70 (2003)
2004  
27
Monoclones, monotypes, and neoplasia pitfalls in lymphoma diagnosis.
[15080295] Am J Clin Pathol 121(4): 457-9 (2004)
2011  
28
Imaging of bone marrow involvement in lymphoma: state of the art and future directions.
[21336455] ScientificWorldJournal 11(-): 391-402 (2011)
2010  
29
Rare causes of calcitriol-mediated hypercalcemia: a case report and literature review.
[20427501] J Clin Endocrinol Metab 95(7): 3111-7 (2010)
2007  
30
Lymphoma dissemination: the other face of lymphocyte homing.
[17656647] Blood 110(9): 3102-11 (2007)
2006  
31
Optimal use of prognostic factors in non-Hodgkin lymphoma.
[17124075] Hematology Am Soc Hematol Educ Program -(-): 295-302 (2006)
2010  
32
2010  
33
Signal transduction inhibitor therapy for lymphoma.
[21239804] Hematology Am Soc Hematol Educ Program 2010(-): 265-70 (2010)
2010  
34
Hematologic disorders after solid organ transplantation.
[21239807] Hematology Am Soc Hematol Educ Program 2010(-): 281-6 (2010)
2007  
35
Etiology and management of therapy-related myeloid leukemia.
[18024664] Hematology Am Soc Hematol Educ Program -(-): 453-9 (2007)
2007  
36
Diagnosis and treatment of childhood non-hodgkin lymphoma.
[18024642] Hematology Am Soc Hematol Educ Program -(-): 285-96 (2007)
2007  
37
Genetic pathways in the pathogenesis of therapy-related myelodysplasia and acute myeloid leukemia.
[18024656] Hematology Am Soc Hematol Educ Program -(-): 392-7 (2007)
2007  
38
Yttrium ibritumomab tiuxetan in the treatment of non-Hodgkin's lymphoma: current status and future prospects.
[19707332] Biologics 1(3): 215-27 (2007)
2008  
39
New monoclonal antibodies for non-Hodgkin's lymphoma.
[18519407] Ann Oncol 19 Suppl 4(-): iv60-2 (2008)
2008  
40
Radiotherapy in non-Hodgkin lymphomas.
[18519403] Ann Oncol 19 Suppl 4(-): iv47-50 (2008)
2009  
41
Rationale for consolidation to improve progression-free survival in patients with non-Hodgkin's lymphoma: a review of the evidence.
[19819921] Oncologist 14 Suppl 2(-): 17-29 (2009)
1995  
42
Molecular pathogenesis of non-Hodgkin lymphoma: a clinical perspective.
[8566891] Haematologica 80(5): 454-72 (1995)
2002  
43
Update on epidemiology and therapeutics for non-Hodgkin's lymphoma.
[12446426] Hematology Am Soc Hematol Educ Program -(-): 241-62 (2002)
2005  
44
Non-Hodgkin lymphoma: diagnosis and treatment.
[16092591] Mayo Clin Proc 80(8): 1087-97 (2005)
2009  
45
Beyond monoclonal antibodies: new therapeutic agents in non-Hodgkin's lymphomas.
[19411316] Oncologist 14(5): 511-25 (2009)
2008  
46
B-cell receptor signaling in the genesis and maintenance of B-cell lymphoma.
[18922114] Future Oncol 4(5): 591-4 (2008)
2010  
47
Monoclonal antibodies for non-Hodgkin's lymphoma: state of the art and perspectives.
[21437222] Clin Dev Immunol 2010(-): 428253 (2010)
2010  
48
Targeted therapy in lymphoma.
[21092307] J Hematol Oncol 3(-): 45 (2010)
2011  
49
Applications of new irradiation modalities in patients with lymphoma: Promises and uncertainties.
[21512653] World J Radiol 3(3): 66-9 (2011)
2008  
50
Developing idiotype vaccines for lymphoma: from preclinical studies to phase III clinical trials.
[18422783] Br J Haematol 142(2): 179-91 (2008)
2008  
51
Chemotherapy combinations with monoclonal antibodies in non-Hodgkin's lymphoma.
[18381103] Semin Hematol 45(2): 90-4 (2008)
2005  
52
Individuals with HGV-RNA are at high risk of B cell non-Hodgkin's lymphoma development.
[16101337] Asian Pac J Cancer Prev 6(2): 215-6 (2005)
2009  
53
New developments in the pathology of malignant lymphoma: a review of the literature published from August to December 2008.
[19669224] J Hematop 2(1): 50-61 (2009)
2011  
54
Beyond chemotherapy: new agents for targeted treatment of lymphoma.
[21151205] Nat Rev Clin Oncol 8(2): 85-96 (2011)
2009  
55
Targeting angiogenesis: a novel, rational therapeutic approach for non-Hodgkin lymphoma.
[19452312] Leuk Lymphoma 50(5): 679-81 (2009)
2009  
56
Treatment of lymphoma with adoptively transferred T cells.
[19723016] Expert Opin Biol Ther 9(11): 1407-25 (2009)
2007  
57
Altered immunity as a risk factor for non-Hodgkin lymphoma.
[17337643] Cancer Epidemiol Biomarkers Prev 16(3): 405-8 (2007)
2007  
58
2007  
59
Benzene exposure and risk of non-Hodgkin lymphoma.
[17337645] Cancer Epidemiol Biomarkers Prev 16(3): 385-91 (2007)
2007  
60
Infectious agents as causes of non-Hodgkin lymphoma.
[17337646] Cancer Epidemiol Biomarkers Prev 16(3): 401-4 (2007)
2007  
61
Occupation and the risk of non-Hodgkin lymphoma.
[17372232] Cancer Epidemiol Biomarkers Prev 16(3): 369-72 (2007)
2010  
62
The IgH 3' regulatory region and its implication in lymphomagenesis.
[21080376] Eur J Immunol 40(12): 3306-11 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Lymphoma (BASKET).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Lymphoma (BASKET).php on line 92